FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups 
 ProfileProfile   PreferencesPreferences   Log in to check your private messagesLog in to check your private messages   Log inLog in 
Forum index » Medicine forums » patology
DHEA and "neuroprotection"
Post new topic   Reply to topic Page 1 of 1 [1 Post] View previous topic :: View next topic
Author Message
James Michael Howard
medicine forum addict


Joined: 30 Apr 2005
Posts: 78

PostPosted: Thu Apr 27, 2006 12:19 pm    Post subject: DHEA and "neuroprotection" Reply with quote

FASEB J. 2006 Mar;20(3):577-9. Epub 2006 Jan 11


G protein-associated, specific membrane binding sites mediate the
neuroprotective effect of dehydroepiandrosterone.

Charalampopoulos I, Alexaki VI, Lazaridis I, Dermitzaki E, Avlonitis N,
Tsatsanis C, Calogeropoulou T, Margioris AN, Castanas E, Gravanis A.

Department of Pharmacology, School of Medicine, University of Crete,
Heraklion, Greece.

The neurosteroid dehydroepiandrosterone (DHEA) at 1 nM protects
NMDA-/GABAA-receptor negative neural crest-derived PC12 cells from
apoptosis. We now report that membrane-impermeable DHEA-BSA conjugate
replaces unconjugated DHEA in protecting serum-deprived PC12 cells from
apoptosis (IC50=1.5 nM). Protection involves phosphorylation of the
prosurvival factor Src and induction of the anti-apoptotic protein Bcl-2
and is sensitive to pertussis toxin. Binding assays of [3H]DHEA on isolated
PC12 cell membranes revealed saturation within 30 min and binding of DHEA
with a Kd of 0.9 nM. A similar binding activity was detectable in isolated
membranes from rat hippocampus and from normal human adrenal chromaffin
cells. The presence of DHEA-specific membrane binding sites was confirmed
by flow cytometry and confocal laser microscopy of DHEA-BSA-FITC stained
cells. In contrast to estrogens and progestins, glucocorticoids and
androgens displaced DHEA from its membrane binding sites but with a 10-fold
lower affinity than DHEA (IC50=9.3 and 13.6 nM, respectively). These agents
acted as pure antagonists, blocking the antiapoptotic effect of DHEA as
well as the induction of Bcl-2 proteins and Src kinase activation. In
conclusion, our findings suggest that neural crest-derived cells possess
specific DHEA membrane binding sites coupled to G proteins. Binding to
these sites confers neuroprotection.
Back to top
Google

Back to top
Display posts from previous:   
Post new topic   Reply to topic Page 1 of 1 [1 Post] View previous topic :: View next topic
The time now is Tue Jun 19, 2018 4:31 am | All times are GMT
Forum index » Medicine forums » patology
Jump to:  

Similar Topics
Topic Author Forum Replies Last Post
No new posts If one has plenty of DHEA, one has plenty of androstenediol James Michael Howard patology 0 Fri Jun 02, 2006 9:53 am
No new posts DHEA for Treatment of Breast Cancer James Michael Howard cancer 0 Tue Apr 25, 2006 12:38 pm
No new posts Raloxigene, Tamoxifen, DHEA, Breast Cancer, and the STAR ... James Michael Howard cancer 0 Tue Apr 18, 2006 6:41 pm
No new posts Raloxigene, Tamoxifen, DHEA, Breast Cancer, and the STAR ... James Michael Howard patology 0 Tue Apr 18, 2006 5:04 pm
No new posts DHEA and mortality James Michael Howard patology 0 Tue Jan 31, 2006 4:54 pm

Copyright © 2004-2005 DeniX Solutions SRL
Other DeniX Solutions sites: email marketing campaigns , electronics forum, Science forum, Unix/Linux blog, Unix/Linux documentation, Unix/Linux forums


Powered by phpBB © 2001, 2005 phpBB Group
[ Time: 0.0111s ][ Queries: 16 (0.0017s) ][ GZIP on - Debug on ]